Qiming’s Portfolio Company Abbisko Lists on Main Board of HKEx
SHANGHAI, Oct. 14, 2021 /PRNewswire/ — Qiming Venture Partners’ portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong Stock Exchange on October 13. The issue price is HK$ 12.46 per…
